Ran Fuhrer

Ran Fuhrer has extensive work experience in various roles and industries. Ran currently serves as the Vice President of Business Development at Neopharm Group since 2018. In 2019, they became a Board Member at Bezeq The Israel Telecommunication Corp. and B Communications Ltd. Ran is also a founding Board Member at LessTests, a company focused on making COVID-19 tests accessible to everyone.

Prior to these roles, Ran served as a Board Member at Walla! from 2019 to 2021. Ran was also a Team Member in the Stanford BioDesign Innovation Program at Stanford Byers Center for Biodesign in 2017. Ran completed the Stanford Sloan Fellows program in 2017, where they gained expertise in various areas including entrepreneurship, venture capital, and organizational behavior.

Earlier in their career, Ran worked at Celgene as a Manager in Hematology & Oncology Global Pricing & Market Access and as a Manager in Business Development. Ran started their career in 2009 as a Business Associate in the Office of the Chairman at Neopharm Group. Ran also served as a Board Member at ADO GROUP from 2010 to 2013.

Overall, Ran Fuhrer has a diverse background with experience in business development, board membership, healthcare, and entrepreneurship.

Ran Fuhrer's education history is as follows:

From 2016 to 2017, Ran attended the Stanford University Graduate School of Business, where they pursued a Master of Science (M.Sc.) in Business.

Between 2009 and 2011, Ran studied at Tel Aviv University, earning a Master of Laws (LL.M.) degree in Law.

In 2010, Ran participated in a student exchange program at the University of California, Berkeley, pursuing a Master of Laws (LL.M.).

In addition to their formal education, Ran has obtained several certifications:

- In 2019, they completed the 8400 Health Technologies / HealthCare Program (Class II) at the Harvard Business School.

- In 2017, they completed the Stanford Biodesign Innovation Program at the Stanford University School of Medicine.

- In 2016, Ran became an Auditor through the Stanford Technology Ventures Program (STVP).

- In 2015, they completed the Exponential Finance Program (XFin) at Singularity University and the Pharmaceutical Management Executive Program at Rutgers Business School.

Ran is also recognized as an Advocate by the Israel Bar Association. They also undertook the Directors and Other Senior Corporate Officeholders program at Lahav Executive Education, Tel-Aviv University, though the specific dates of completion are unknown.